CA Patent

CA2974578C — Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function

Assigned to Park Therapeutics Inc · Expires 2020-11-17 · 5y expired

What this patent protects

The invention relates to Cebranopadol or a physiologically acceptable salt thereof for use in the treatment or the prevention of pain and/or opioid drug dependence in a subject with impaired hepatic and/or renal function.

USPTO Abstract

The invention relates to Cebranopadol or a physiologically acceptable salt thereof for use in the treatment or the prevention of pain and/or opioid drug dependence in a subject with impaired hepatic and/or renal function.

Drugs covered by this patent

Patent Metadata

Patent number
CA2974578C
Jurisdiction
CA
Classification
—
Expires
2020-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Park Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.